Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections
Huibin Lv(HKU-Pasteur Research Pole), Chris Ka Pun Mok(Chinese University of Hong Kong), Chris Yau Chung Choi(Hospital Authority), Thomas Shiu Hong Chik(Hospital Authority), Ray T. Y. So(University of Hong Kong), Jincun Zhao(ShanghaiTech University), Meng Yuan(Ministry of Education of the People's Republic of China), Ranawaka A. P. M. Perera(University of Pennsylvania), Leo L. M. Poon(Hong Kong Science and Technology Parks Corporation), Malik Peiris(Biology of Infection), Wai-Shing Leung(Hospital Authority), Owen Tak-Yin Tsang(Hospital Authority), Yiquan Wang(University of Illinois Urbana-Champaign), Garrick K. Yip(University of Hong Kong), Yi‐Han Lin(University of Washington), Wilson W. Ng(University of Hong Kong), Jacky Man Chun Chan(Hospital Authority), Nicholas C. Wu(University of Illinois Urbana-Champaign), Ian A. Wilson(Raigmore Hospital)
Cited by 450
Related Papers
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
|The Lancet Infectious Diseases|2020|3.4k
Consistent Detection of 2019 Novel Coronavirus in Saliva
|Clinical Infectious Diseases|2020|2k
Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia
|Nature Medicine|2006|1.9k
Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
|The Lancet|2020|1.6k
Influenza
|Nature Reviews Disease Primers|2018|1.5k